Evidence map›Paper›PMID 21538556›Full record

ReviewEnvironmental and molecular mutagenesis2011

Genetic toxicology in the 21st century: reflections and future directions.

Brinda Mahadevan, Ronald D Snyder, Michael D Waters, R Daniel Benz, Raymond A Kemper, Raymond R Tice, Ann M Richard

Open access · greenAbstract readReview
In one paragraph

Review in Environmental and molecular mutagenesis, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. In Silico Approaches in Predictive Genetic Toxicology.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Machine Learning for In Silico ADMET Prediction.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  8. Article
  9. Article
  10. Genetic toxicology in silico protocol.Regulatory toxicology and pharmacology : RTP · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Impact of Novel Assessment Methodologies in Toxicology on Green Chemistry and Chemical Alternatives.Toxicological sciences : an official journal of the Society of Toxicology · 2018
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Brinda MahadevanMerck Research Laboratories, Genetic Toxicology, Mechanistic and Predictive Toxicology, Summit, New Jersey, USA. brinda.mahadevan@abbott.com
Ronald D Snyder
Michael D Waters
R Daniel Benz
Raymond A Kemper
Raymond R Tice
Ann M Richard
Merck & Co., Inc., Rahway, NJ, USA (United States) · USBoehringer Ingelheim (United States) · USIntegrated Laboratory Systems, Inc. · USNational Institute of Environmental Health Sciences · USResearch Triangle Park Foundation · USUnited States Food and Drug Administration · US

Funding

Intramural NIH HHS Z99 ES999999
6 · The paper itself

Abstract

A symposium at the 40th anniversary of the Environmental Mutagen Society, held from October 24-28, 2009 in St. Louis, MO, surveyed the current status and future directions of genetic toxicology. This article summarizes the presentations and provides a perspective on the future. An abbreviated history is presented, highlighting the current standard battery of genotoxicity assays and persistent challenges. Application of computational toxicology to safety testing within a regulatory setting is discussed as a means for reducing the need for animal testing and human clinical trials, and current approaches and applications of in silico genotoxicity screening approaches across the pharmaceutical industry were surveyed and are reported here. The expanded use of toxicogenomics to illuminate mechanisms and bridge genotoxicity and carcinogenicity, and new public efforts to use high-throughput screening technologies to address lack of toxicity evaluation for the backlog of thousands of industrial chemicals in the environment are detailed. The Tox21 project involves coordinated efforts of four U.S. Government regulatory/research entities to use new and innovative assays to characterize key steps in toxicity pathways, including genotoxic and nongenotoxic mechanisms for carcinogenesis. Progress to date, highlighting preliminary test results from the National Toxicology Program is summarized. Finally, an overview is presented of ToxCast™, a related research program of the U.S. Environmental Protection Agency, using a broad array of high throughput and high content technologies for toxicity profiling of environmental chemicals, and computational toxicology modeling. Progress and challenges, including the pressing need to incorporate metabolic activation capability, are summarized.

Indexed as

Environmental MonitoringModels, TheoreticalToxicogeneticsUnited StatesUnited States Environmental Protection Agency

Identifiers

PMID21538556
PMCPMC3160238
OpenAlexW2070967244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.